Location History:
- Edmunds, GB (2006 - 2007)
- Bury St. Edmunds, GB (2003 - 2022)
Company Filing History:
Years Active: 2003-2022
Title: Innovations of Peter D McDonnell
Introduction
Peter D McDonnell is a notable inventor based in Bury St Edmunds, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of type 2 diabetes. With a total of 4 patents to his name, McDonnell's work showcases his dedication to advancing medical science.
Latest Patents
One of McDonnell's latest patents is focused on crosslinked polydiallyamine copolymers for the treatment of type 2 diabetes. These copolymers, which consist of monomers of polydiallylamine and either polyvinylamine or polyallylamine, are often crosslinked. They are useful as pharmaceutical compositions and may help in treating type 2 diabetes and mitigating its complications. Another significant patent involves the synthesis of substituted thiazoline carboxylic acids. This efficient method prepares alkylated thiazoline carboxylic acids through a series of chemical reactions, including the coupling of substituted aryl nitriles with cysteine esters.
Career Highlights
Peter D McDonnell is currently associated with Genzyme Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new treatments that address critical health issues.
Collaborations
Throughout his career, McDonnell has collaborated with esteemed colleagues such as Mukund Shankar Chorghade and Rayomand H Gimi. These partnerships have further enriched his research and development efforts.
Conclusion
Peter D McDonnell's contributions to the field of pharmaceuticals, particularly in diabetes treatment, highlight his innovative spirit and commitment to improving health outcomes. His patents reflect a blend of creativity and scientific rigor that continues to influence the industry.